SCHEMBL7989566

SCHEMBL7989566

CCCCCc1nc(O)c2c(ncn2Cc2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 2/20 0.41
ADORA2B P29275 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
POLB P06746 1/20 0.39
HIF1A Q16665 1/20 0.39
TNF P01375 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
GAA P10253 1/20 0.39
CYP19A1 P11511 3/20 0.38
CNOT7 Q9UIV1 4/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987609 0.96 PDE4A (0.43) HPGDSMN1; SMN2ALDH1A1ADORA2BRXFP1
SCHEMBL7989407 0.93 HPGD (0.44) HPGDSMN1; SMN2ALDH1A1ADORA2BRXFP1
SCHEMBL7988839 0.87 SMN1; SMN2 (0.45) HPGDSMN1; SMN2ALDH1A1ADORA2BRXFP1
SCHEMBL7985319 0.87 SMN1; SMN2 (0.42) HPGDSMN1; SMN2ALDH1A1ADORA2BRXFP1
SCHEMBL7975252 0.86 HPGD (0.45) HPGDSMN1; SMN2ALDH1A1ADORA2BRXFP1
Hydrochloric Acid SCHEMBL7975098 0.86 SMN1; SMN2 (0.44) HPGDSMN1; SMN2ALDH1A1ADORA2BRXFP1
Hydrochloric Acid SCHEMBL7987745 0.86 SMN1; SMN2 (0.41) HPGDSMN1; SMN2ALDH1A1ADORA2BRXFP1
SCHEMBL7985637 0.84 SMN1; SMN2 (0.43) HPGDSMN1; SMN2ALDH1A1ADORA2BRXFP1
SCHEMBL7987704 0.83 SMN1; SMN2 (0.46) HPGDSMN1; SMN2ALDH1A1ADORA2BRXFP1
Hydrochloric Acid SCHEMBL7987616 0.83 SMN1; SMN2 (0.42) HPGDSMN1; SMN2ALDH1A1ADORA2BRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed